PHARMACOKINETIC INTERACTION BETWEEN IVACAFTOR AND LUMACAFTOR IN CYSTIC FIBROSIS PATIENTS

被引：0
|
作者：
Hanafin, P. [2 ]
Rao, G. [2 ]
Schneider-Futschik, E. [1 ]
机构：
[1] Univ Melbourne, Melbourne, Vic, Australia
[2] UNC Eshelman Sch Pharm, Chapel Hill, NC USA
来源：
RESPIROLOGY | 2020年 / 25卷
基金：
英国医学研究理事会;
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
TO 070
引用
收藏
页码：58 / 58
页数：1
相关论文
共 50 条
  • [31] Computed Tomographic Changes in Patients with Cystic Fibrosis Treated by Combination Therapy with Lumacaftor and Ivacaftor
    Arnaud, Francois
    Stremler-Le Bel, Nathalie
    Reynaud-Gaubert, Martine
    Mancini, Julien
    Gaubert, Jean-Yves
    Gorincour, Guillaume
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (09)
  • [32] Patients with cystic fibrosis and advanced lung disease benefit from lumacaftor/ivacaftor treatment
    Ejiofor, Linnea Chika Kristensen
    Mathiesen, Inger Hee Mabuza
    Jensen-Fangel, Soren
    Olesen, Hanne Vebert
    Skov, Marianne
    Philipsen, Lue Katrine Drasbaek
    Pedersen, Camilla Lundgren
    Pressler, Tacjana
    PEDIATRIC PULMONOLOGY, 2020, 55 (12) : 3364 - 3370
  • [33] Lumacaftor/ Ivacaftor improves exercise tolerance in patients with Cystic Fibrosis and severe airflow obstruction
    Peter A. B. Wark
    Kim Cookson
    Theeba Thiruchelvam
    John Brannan
    Douglas J. Dorahy
    BMC Pulmonary Medicine, 19
  • [34] COST EFFECTIVENESS OF IVACAFTOR AND LUMACAFTOR COMBINATION FOR THE TREATMENT OF PATIENTS WITH CYSTIC FIBROSIS IN THE UNITED STATES
    Sharma, D.
    Xing, S.
    Hung, Y.
    Caskey, R. N.
    Dowell, M. L.
    Touchette, D. R.
    VALUE IN HEALTH, 2016, 19 (07) : A431 - A432
  • [35] Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis
    Burgel, Pierre-Regis
    Munck, Anne
    Durieu, Isabelle
    Chiron, Raphael
    Mely, Laurent
    Prevotat, Anne
    Murris-Espin, Marlene
    Porzio, Michele
    Abely, Michel
    Reix, Philippe
    Marguet, Christophe
    Macey, Julie
    Sermet-Gaudelus, Isabelle
    Corvol, Harriet
    Bui, Stephanie
    Lemonnier, Lydie
    Dehillotte, Clemence
    Da Silva, Jennifer
    Paillasseur, Jean-Louis
    Hubert, Dominique
    Mounard, Julie
    Poulet, Claire
    Rames, Cinthia
    Person, Christine
    Troussier, Francoise
    Urban, Thierry
    Dalphin, Marie-Laure
    Dalphin, Jean-Claude
    Pernet, Didier
    Richaud-Thiriez, Benedicte
    Fayon, Mickael
    Macey-Caro, Julie
    Campbell, Karine
    Laurans, Muriel
    Borderon, Corinne
    Heraud, Marie-Christine
    Labbe, Andre
    Montcouquiol, Sylvie
    Bassinet, Laurence
    Remus, Natascha
    Fanton, Annlyse
    Houzel-Charavel, Anne
    Huet, Frederic
    Perez-Martin, Stephanie
    Boldron-Ghaddar, Amale
    Scalbert, Manuela
    Camara, Boubou
    Llerena, Catherine
    Pin, Isabelle
    Quetant, Sebastien
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201 (02) : 188 - 197
  • [36] Real World Assessment of Patients with Cystic Fibrosis Treated with Lumacaftor-Ivacaftor and Transitioned to Tezacaftor-Ivacaftor
    Christmas, A.
    O'Hagan, A. R.
    Morton, R. L.
    Eid, N. S.
    Bickel, S. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [37] Lumacaftor/ivacaftor in cystic fibrosis: effects on glucose metabolism and insulin secretion
    C. Colombo
    A. Foppiani
    A. Bisogno
    S. Gambazza
    V. Daccò
    E. Nazzari
    A. Leone
    A. Giana
    A. Mari
    A. Battezzati
    Journal of Endocrinological Investigation, 2021, 44 : 2213 - 2218
  • [38] Physiologically-based pharmacokinetic modeling of the drug-drug interaction between ivacaftor and lefamulin in cystic fibrosis patients
    Amiel, Magali
    Ke, Alice
    Gelone, Steven P.
    Jones, Hannah M.
    Wicha, Wolfgang
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (04): : 589 - 598
  • [39] The use of lumacaftor/ivacaftor to treat acute deterioration in paediatric cystic fibrosis
    Hammond, James A.
    Connett, Gary J.
    PAEDIATRIC RESPIRATORY REVIEWS, 2018, 27 : 16 - 17
  • [40] Lumacaftor/ivacaftor in cystic fibrosis: effects on glucose metabolism and insulin secretion
    Colombo, C.
    Foppiani, A.
    Bisogno, A.
    Gambazza, S.
    Dacco, V
    Nazzari, E.
    Leone, A.
    Giana, A.
    Mari, A.
    Battezzati, A.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2021, 44 (10) : 2213 - 2218
12345